BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 16198250)

  • 21. Why should we care about CARE-HF?
    Ellenbogen KA; Wood MA; Klein HU
    J Am Coll Cardiol; 2005 Dec; 46(12):2199-203. PubMed ID: 16360046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry.
    Gilliam FR; Kaplan AJ; Black J; Chase KJ; Mullin CM
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):56-64. PubMed ID: 17241316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy.
    Michelucci A; Ricciardi G; Sofi F; Gori AM; Pirolo F; Pieragnoli P; Giaccardi M; Colella A; Porciani MC; Di Biase L; Padeletti L; Abbate R; Gensini GF
    J Card Fail; 2007 Apr; 13(3):207-10. PubMed ID: 17448418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired heart rate responses and exercise capacity in heart failure patients with paced baseline rhythms.
    Ujeyl A; Stevenson LW; West EK; Kato M; Liszkowski M; Campbell P; Forman DE
    J Card Fail; 2011 Mar; 17(3):188-95. PubMed ID: 21362525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization therapy for treatment of heart failure in the elderly.
    Kron J; Conti JB
    Clin Geriatr Med; 2007 Feb; 23(1):193-203. PubMed ID: 17126762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity.
    Piepoli MF; Villani GQ; Corrà U; Aschieri D; Rusticali G
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):701-8. PubMed ID: 18507542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cardiac resynchronization therapy on muscle sympathetic nerve activity.
    Kuniyoshi RR; Martinelli M; Negrão CE; Siqueira SF; Rondon MU; Trombetta IC; Kuniyoshi FH; Laterza MC; Nishioka SA; Costa R; Tamaki WT; Crevelari ES; Peixoto Gde L; Ramires JA; Kalil R
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):11-8. PubMed ID: 23952584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The muscle hypothesis: a model of chronic heart failure appropriate for osteopathic medicine.
    Rogers FJ
    J Am Osteopath Assoc; 2001 Oct; 101(10):576-83. PubMed ID: 11681164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
    Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
    Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of heart failure in right univentricular pacing compared to biventricular pacing.
    Ritter O; Koller ML; Fey B; Seidel B; Krein A; Langenfeld H; Bauer WR
    Int J Cardiol; 2006 Jun; 110(3):359-65. PubMed ID: 16297471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.